Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice
Shima Bastaki, A. Surendar, Nasrin Ahmadpour Saheb, et al.
Life Sciences (2020) Vol. 266, pp. 118847-118847
Closed Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

Harnessing polyelectrolyte complexes for precision cancer targeting: a comprehensive review
Bhupendra G. Prajapati, Jai Bharti Sharma, Swapnil Sharma, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 4
Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection
Varvara Antoniou, Elena A. Mourelatou, Eleftheria Galatou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 868-868
Open Access | Times Cited: 4
Microbial polysaccharides: An emerging family of natural biomaterials for cancer therapy and diagnostics
Prateeksha, Vivek Sharma, Xiaowen Liu, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 706-731
Open Access | Times Cited: 30
Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies—Reviewing Thiomers from Chitosan and Hyaluronic Acid
Roberto Grosso, M.‐Violante de‐Paz
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 854-854
Open Access | Times Cited: 28
Enhanced drug release from a pH-responsive nanocarrier can augment colon cancer treatment by blocking PD-L1 checkpoint and consuming tumor glucose
Kai Guo, Yixuan Liu, Min Ding, et al.
Materials & Design (2022) Vol. 219, pp. 110824-110824
Open Access | Times Cited: 19
Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology
Tuan Hiep Tran, Thi Thu Phuong Tran
Royal Society Open Science (2022) Vol. 9, Iss. 4
Open Access | Times Cited: 16
RETRACTED: Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 288, pp. 120166-120166
Closed Access | Times Cited: 21
Insight into chitosan derived nanotherapeutics for anticancer drug delivery and imaging
Nimish Moramkar, Purvi Bhatt
European Polymer Journal (2021) Vol. 154, pp. 110540-110540
Closed Access | Times Cited: 20
Polymeric nanomaterial strategies to encapsulate and deliver biological drugs: points to consider between methods
Chen Xiangxun, Yuao Wu, Van Thanh Dau, et al.
Biomaterials Science (2023) Vol. 11, Iss. 6, pp. 1923-1947
Closed Access | Times Cited: 8
Effective Strategies in Designing Chitosan-hyaluronic Acid Nanocarriers: From Synthesis to Drug Delivery Towards Chemotherapy
Long-Quy Hong, Thao N. T. Ho, Son T. Cu, et al.
Current Drug Delivery (2024) Vol. 22, Iss. 1, pp. 41-62
Closed Access | Times Cited: 2
Immune‐related adverse events of antibody‐based biological medicines in cancer therapy
Deepa Rajagopal, Elliot MacLeod, Diana Corogeanu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 2
Chitosan-based nanoarchitectures for siRNA delivery in cancer therapy: A review of pre-clinical and clinical importance
Xiaobo Bian, Xiaopeng Yu, Shiyang Lu, et al.
International Journal of Biological Macromolecules (2024), pp. 137708-137708
Closed Access | Times Cited: 2
Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles
Armita Mahdavi Gorabi, Mehrnaz Sadat Ravari, Mohammad‐Javad Sanaei, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109300-109300
Closed Access | Times Cited: 13
Rolling Circle Amplification-Based DNA Nano-Assembly for Targeted Drug Delivery and Gene Therapy
Zhiqing Zhang, Dongyan Xu, Jiawei Wang, et al.
Biomacromolecules (2022) Vol. 24, Iss. 1, pp. 439-448
Closed Access | Times Cited: 13
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1851-1866
Closed Access | Times Cited: 9
Role of lysosome in healing neurological disorders by nano-bioengineering
Aiswarya Raj, Urmi Bandyopadhyay
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 1
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Kangning Wang, Kan Zhou, Nian‐Nian Zhong, et al.
Life Sciences (2024) Vol. 346, pp. 122635-122635
Closed Access | Times Cited: 1
Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers
Mehdi Sanati, Christian G. Figueroa‐Espada, Emily L. Han, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103868-103868
Closed Access | Times Cited: 8
Non-coding RNAs in Regulating Tumor Angiogenesis
Xin Song, Junming Guo, Peng Song, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11
Enhanced Cytotoxic Effect of TAT–PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia
Ylenia Jabalera, Alberto Sola‐Leyva, Salvatore Calogero Gaglio, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1168-1168
Open Access | Times Cited: 9
Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape
Juliana Santos Rosa Viegas, Maria Vitória Lopes Badra Bentley, Fabiana T. M. C. Vicentini
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103964-103964
Closed Access | Times Cited: 6
Novel fabrication of marizomib-loaded chitosan-coated hydroxyapatite nanocarriers as a promising system for effective treatment of ovarian cancer
Jia Ming Xu, Meimei Liao, Yi Chen, et al.
Materials Research Express (2022) Vol. 9, Iss. 3, pp. 035403-035403
Open Access | Times Cited: 5
Emerging Advances in Nanomedicine for Breast Cancer Immunotherapy: Opportunities and Challenges
Mohammad Zaki Ahmad, Ali Alasiri, Mohammed Yahia Alasmary, et al.
Immunotherapy (2022) Vol. 14, Iss. 12, pp. 957-983
Closed Access | Times Cited: 5
Potential roles of hyaluronic acid inin vivoCAR T cell reprogramming for cancer immunotherapy
Chavee Laomeephol, Sudartip Areecheewakul, Supannikar Tawinwung, et al.
Nanoscale (2022) Vol. 14, Iss. 48, pp. 17821-17840
Open Access | Times Cited: 5

Scroll to top